Rapid Multiplex Testing for Upper Respiratory Pathogens in the Emergency Department: A Randomized Controlled Trial

Larissa May, Grant Tatro, Eduard Poltavskiy, Benjamin Mooso, Simson Hon, Heejung Bang, Christopher Polage, Larissa May, Grant Tatro, Eduard Poltavskiy, Benjamin Mooso, Simson Hon, Heejung Bang, Christopher Polage

Abstract

Background: Acute upper respiratory tract infections are a common cause of emergency department (ED) visits and often result in unnecessary antibiotic treatment.

Methods: We conducted a randomized clinical trial to evaluate the impact of a rapid, multipathogen respiratory panel (RP) test vs usual care (control). Patients were eligible if they were ≥12 months old, had symptoms of upper respiratory infection or influenza-like illness, and were not on antibiotics. The primary outcome was antibiotic prescription; secondary outcomes included antiviral prescription, disposition, and length of stay (ClinicalTrials.gov# NCT02957136).

Results: Of 191 patients enrolled, 93 (49%) received RP testing; 98 (51%) received usual care. Fifty-three (57%) RP and 7 (7%) control patients had a virus detected and reported during the ED visit (P = .0001). Twenty (22%) RP patients and 33 (34%) usual care patients received antibiotics during the ED visit (-12%; 95% confidence interval, -25% to 0.4%; P = .06/0.08); 9 RP patients received antibiotics despite having a virus detected. The magnitude of antibiotic reduction was greater in children (-19%) vs adults (-9%, post hoc analysis). There was no difference in antiviral use, length of stay, or disposition.

Conclusions: Rapid RP testing was associated with a trend toward decreased antibiotic use, suggesting a potential benefit from more rapid viral tests in the ED. Future studies should determine if specific groups are more likely to benefit from testing and evaluate the relative cost and effectiveness of broad testing, focused testing, and a combined diagnostic and antimicrobial stewardship approach.

Keywords: Upper respiratory tract infection; antibiotic treatment; diagnostic test; emergency department; randomized clinical trial.

© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
CONSORT diagram.

References

    1. Donnelly JP, Baddley JW, Wang HE. Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments. Antimicrob Agents Chemother 2014; 58:1451–7.
    1. Barlam TF, Soria-Saucedo R, Cabral HJ, et al. . Unnecessary antibiotics for acute respiratory tract infections: association with care setting and patient demographics. Open forum Infect Dis 2016; 3:ofw045.
    1. May L, Cosgrove S, L’Archeveque M, et al. . A call to action for antimicrobial stewardship in the emergency department: approaches and strategies. Ann Emerg Med 2013; 62:69–77.e2.
    1. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47:735–43.
    1. Stearns CR, Gonzales R, Camargo CA Jr, et al. . Antibiotic prescriptions are associated with increased patient satisfaction with emergency department visits for acute respiratory tract infections. Acad Emerg Med 2009; 16:934–41.
    1. Andrews D, Chetty Y, Cooper BS, et al. . Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 2017; 17:671.
    1. Echavarría M, Marcone DN, Querci M, et al. . Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection. J Clin Virol 2018; 108:90–5.
    1. Poritz MA, Blaschke AJ, Byington CL, et al. . FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 2011; 6:e26047.
    1. Green DA, Hitoaliaj L, Kotansky B, et al. . Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol 2016; 54:2950–5.
    1. Zoorob R, Sidani MA, Fremont RD, Kihlberg C. Antibiotic use in acute upper respiratory tract infections. Am Fam Physician 2012; 86: 817–22.
    1. Dugas AF, Valsamakis A, Atreya MR, et al. . Clinical diagnosis of influenza in the ED. Am J Emerg Med 2015; 33:770–5.
    1. Rogers BB, Shankar P, Jerris RC, et al. . Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med 2015; 139:636–41.
    1. Xu M, Qin X, Astion ML, et al. . Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol 2013; 139:118–23.
    1. Brendish NJ, Malachira AK, Armstrong L, et al. . Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017; 5:401–11.
    1. Brendish NJ, Malachira AK, Beard KR, et al. . Imact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial. Eur Respir J 2018; 52:1800555.
    1. Chen XH, Wang JH, Yao XH. Clinical utility of a near patient care microarray based diagnostic test for influenza and respiratory syncytial virus infections. Int J Clin Exp Med 2015; 8:16504–11.
    1. GenomeWeb. Palmetto final LCD denies coverage to large respiratory panels. 2018. Available at: Accessed 19 November 2019.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren